Miklós Egyed

5.5k total citations
95 papers, 1.6k citations indexed

About

Miklós Egyed is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Miklós Egyed has authored 95 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Genetics, 53 papers in Hematology and 28 papers in Molecular Biology. Recurrent topics in Miklós Egyed's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (46 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Eosinophilic Disorders and Syndromes (20 papers). Miklós Egyed is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (46 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Eosinophilic Disorders and Syndromes (20 papers). Miklós Egyed collaborates with scholars based in Hungary, France and United States. Miklós Egyed's co-authors include Jean‐Jacques Kiladjian, Timothy Devos, Ruben A. Mesa, Alessandro M. Vannucchi, Heinz Gisslinger, Roman Hájek, Elena Tóthová, Heinz Ludwig, Richard Greil and Niklas Zojer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Miklós Egyed

85 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Miklós Egyed 1.1k 982 806 374 318 95 1.6k
Musa Yılmaz 1.5k 1.4× 596 0.6× 689 0.9× 193 0.5× 553 1.7× 149 2.0k
Pascale Cony‐Makhoul 1.3k 1.2× 864 0.9× 257 0.3× 502 1.3× 318 1.0× 76 1.5k
Jorge Vela‐Ojeda 1.1k 1.0× 668 0.7× 258 0.3× 400 1.1× 346 1.1× 79 1.5k
Vamsi Kota 887 0.8× 397 0.4× 397 0.5× 143 0.4× 408 1.3× 156 1.4k
Giulia Benevolo 846 0.8× 511 0.5× 658 0.8× 135 0.4× 436 1.4× 54 1.2k
Jamile M. Shammo 874 0.8× 587 0.6× 429 0.5× 96 0.3× 305 1.0× 79 1.5k
Kerry Taylor 1.6k 1.5× 1.1k 1.2× 260 0.3× 712 1.9× 350 1.1× 28 2.0k
Devendra Hiwase 944 0.9× 489 0.5× 378 0.5× 174 0.5× 296 0.9× 107 1.3k
Elias Jabbour 955 0.9× 561 0.6× 306 0.4× 269 0.7× 255 0.8× 67 1.3k
Jiří Mayer 748 0.7× 679 0.7× 162 0.2× 320 0.9× 161 0.5× 48 1.0k

Countries citing papers authored by Miklós Egyed

Since Specialization
Citations

This map shows the geographic impact of Miklós Egyed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Egyed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Egyed more than expected).

Fields of papers citing papers by Miklós Egyed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miklós Egyed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Egyed. The network helps show where Miklós Egyed may publish in the future.

Co-authorship network of co-authors of Miklós Egyed

This figure shows the co-authorship network connecting the top 25 collaborators of Miklós Egyed. A scholar is included among the top collaborators of Miklós Egyed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miklós Egyed. Miklós Egyed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasselbalch, Hans Carl, Vibe Skov, Lasse Kjær, et al.. (2024). The CHIP-clinic as the catalyst of preventive medicine. SHILAP Revista de lepidopterología. 3. 1 indexed citations
2.
Oh, Stephen T., Srđan Verstovšek, Vikas Gupta, et al.. (2024). Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. SHILAP Revista de lepidopterología. 5(1). 105–116. 12 indexed citations
3.
Gisslinger, Heinz, Valerio De Stefano, Vincenzo Accurso, et al.. (2023). Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study. European Journal Of Haematology. 112(3). 379–391. 1 indexed citations
4.
Prohászka, Zoltán, Tibor Kalmár, Gábor Késmárky, et al.. (2022). Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50. Frontiers in Immunology. 13. 919411–919411. 9 indexed citations
5.
Egyed, Miklós, et al.. (2020). Is iron deficiency anemia always microcytic?. Polskie Archiwum Medycyny Wewnętrznej. 131(2). 199–201. 1 indexed citations
6.
Gotić, Mirjana, Miklós Egyed, Liana Gercheva, et al.. (2020). Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia. Cardiovascular Toxicology. 21(3). 236–247. 4 indexed citations
7.
Grießhammer, Martin, Güray Saydam, Francesca Palandri, et al.. (2018). Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial. Annals of Hematology. 97(9). 1591–1600. 41 indexed citations
8.
Mesa, Ruben A., Jean‐Jacques Kiladjian, John Catalano, et al.. (2017). SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis. Journal of Clinical Oncology. 35(34). 3844–3850. 238 indexed citations
9.
Kállay, Krisztián, Miklós Egyed, István Vályi‐Nagy, et al.. (2017). Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary. Pathology & Oncology Research. 24(1). 83–88. 8 indexed citations
10.
Dreyling, Martin, Panayiotis Panayiotidis, Miklós Egyed, et al.. (2017). Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial. Blood. 130. 4053–4053. 3 indexed citations
11.
Mesa, Ruben A., Alessandro M. Vannucchi, Adam J. Mead, et al.. (2017). Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial. The Lancet Haematology. 4(5). e225–e236. 221 indexed citations
12.
Chanan‐Khan, Asher, Miklós Egyed, Tadeusz Robak, et al.. (2017). Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial). Leukemia. 31(5). 1240–1243. 21 indexed citations
13.
Rosta, András, Hajna Losonczy, Miklós Egyed, et al.. (2017). Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study). Pathology & Oncology Research. 24(2). 199–205. 4 indexed citations
14.
Chanan‐Khan, Asher, Andrey Zaritskey, Miklós Egyed, et al.. (2017). Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Haematology. 4(11). e534–e543. 29 indexed citations
15.
16.
Ludwig, Heinz, Roman Hájek, Elena Tóthová, et al.. (2008). Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Blood. 113(15). 3435–3442. 148 indexed citations
17.
Egyed, Miklós, et al.. (2006). [Neutropenia and sepsis in hematologic patients].. PubMed. 147(42). 2031–3. 1 indexed citations
18.
Pajor, László, et al.. (2004). Increased incidence of monoclonal B-cell infiltrate in chronic myeloproliferative disorders. Modern Pathology. 17(12). 1521–1530. 7 indexed citations
19.
Lashof, Astrid M. L. Oude, R. De Bock, Raoul Herbrecht, et al.. (2004). An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. European Journal of Cancer. 40(9). 1314–1319. 28 indexed citations
20.
Egyed, Miklós, et al.. (2003). Effect of Retinoic Acid Treatment on Cytogenetic Remission of Chronic Myeloid Leukaemia. Acta Haematologica. 109(2). 84–89. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Musa Yılmaz Breakdown of academic impact, for papers by Pascale Cony‐Makhoul Breakdown of academic impact, for papers by Jorge Vela‐Ojeda Breakdown of academic impact, for papers by Vamsi Kota Breakdown of academic impact, for papers by Giulia Benevolo Breakdown of academic impact, for papers by Jamile M. Shammo Breakdown of academic impact, for papers by Kerry Taylor Breakdown of academic impact, for papers by Devendra Hiwase Breakdown of academic impact, for papers by Elias Jabbour Breakdown of academic impact, for papers by Jiří Mayer
Rankless by CCL
2026